Pharmaceutical Industry Reports Rivaroxaban market Click to read
  • Comments

Pharmaceutical Industry Reports

Rivaroxaban market

Published on in “Health & Fitness, Science”, language — English. 8 pages.
Rivaroxaban is a Non-Vitamin K Antagonist Oral Anticoagulants (NOAC) that is marketed as Xarelto. Anticoagulant medicines are potent therapeutic agents used in the prevention or treatment of serious illnesses and potentially life-threatening conditions associated with blood coagulation. More

Other publications of “Pharmaceutical Industry Reports”

View all publications